GlassScriptPhysician profile
Mark M Jones
NPI 1871536235
$2,377,892.91
in general payments reported to CMS, 2019-2025
8 companies · $6,094 in 2025
The $6,094 reported for 2025 was more than what 75% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $2.0M · 2021: $249K · 2022: $21K · 2023: $57K · 2024: $147 · 2025: $6,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $63K · Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $62,780.26 |
| Food and Beverage | $440.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,043,018.03 | 2020 | |
| Medtronic, INC. | $332,596.28 | 2021-2025 | Ellipsys Vascular Access System |
| Medical Device Business Services, INC. | $1,101.67 | 2019-2021 | |
| Stryker Corporation | $570.88 | 2019-2022 | |
| Davol INC. | $294.16 | 2023 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $213.09 | 2019-2024 | Attune, Velys |
| Fortis Surgical, LLC | $98.80 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$725,120.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.